Bicycle Therapeutics (BCYC) Non Operating Income (2018 - 2026)

Bicycle Therapeutics has reported Non Operating Income for 9 years, with the latest figure at $4.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 42.26% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $24.7 million (down 37.62% YoY), and the FY2025 full-year result was $28.3 million, down 21.67% from the prior year.
• Non Operating Income for Q1 2026 stood at $4.8 million, down from $5.8 million in the prior quarter.
• The five-year high for Non Operating Income was $14.7 million in Q4 2024, with the low at -$600000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $4.8 million across 5 years, with a median of $4.8 million in 2026.
• Annual changes were most pronounced in 2023 — Non Operating Income plunged 136.0% — and 2024, when it soared 77322.22%.
• Bicycle Therapeutics' Non Operating Income stood at $1.8 million in 2022, then surged by 200.94% to $5.5 million in 2023, then jumped by 169.92% to $14.7 million in 2024, then plunged by 60.49% to $5.8 million in 2025, then retreated by 17.01% to $4.8 million in 2026.
• The last three Non Operating Income figures came in at $4.8 million (Q1 2026), $5.8 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.